Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 23, 2023

Zydus Pharms Usa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ZYDUS PHARMS USA, and what generic and branded alternatives to ZYDUS PHARMS USA drugs are available?

ZYDUS PHARMS USA has fifty-seven approved drugs.

There are seventeen tentative approvals on ZYDUS PHARMS USA drugs.

Summary for Zydus Pharms Usa

US Patents:	0
Tradenames:	48
Ingredients:	48
NDAs:	57

Drugs and US Patents for Zydus Pharms Usa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa Inc	TOPIRAMATE	topiramate	CAPSULE;ORAL	078877-002	Oct 14, 2009	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa	AZATHIOPRINE	azathioprine	TABLET;ORAL	077621-002	Sep 5, 2008	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa	NAPROXEN	naproxen	TABLET;ORAL	078620-001	Jun 7, 2007	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	TABLET;ORAL	077653-002	Jun 13, 2008	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	090175-002	May 10, 2011		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	090321-002	Mar 25, 2011	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

McKinsey

AstraZeneca

Johnson and Johnson

Medtronic

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.